Sloning BioTechnology GmbH – Trademark Portfolio
Entity Type: 99
Sloning BioTechnology GmbH holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SLONOMICS. The owner is based in Planegg.
Semmelweisstrasse 7
Planegg 82152 , DE
Showing of trademarks Trademarks
Trademark Classifications
Sloning BioTechnology GmbH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Sloning BioTechnology GmbH have?
Sloning BioTechnology GmbH has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Sloning BioTechnology GmbH file in?
Sloning BioTechnology GmbH files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Sloning BioTechnology GmbH's most well-known trademarks?
Sloning BioTechnology GmbH's registered trademark portfolio includes well-known marks such as SLONOMICS. These are among 1 currently registered trademark in the portfolio.
What is Sloning BioTechnology GmbH's trademark registration success rate?
Sloning BioTechnology GmbH has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.